Cargando…

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.

Two hundred and eighty-four patients with advanced Hodgkin's disease (HD) (stage II with poor prognostic features and stage III/IV) have been treated with the ChlVPP combination chemotherapy regimen (chlorambucil, vinblastine, procarbazine and prednisolone) in a single-centre unselected series....

Descripción completa

Detalles Bibliográficos
Autores principales:	Selby, P., Patel, P., Milan, S., Meldrum, M., Mansi, J., Mbidde, E., Brada, M., Perren, T., Forgeson, G., Gore, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971832/ https://www.ncbi.nlm.nih.gov/pubmed/2386744

Ejemplares similares

Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma
por: Cocorocchio, E, et al.
Publicado: (2010)

Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
por: Dady, P. J., et al.
Publicado: (1982)

ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial
por: Hancock, B W, et al.
Publicado: (2001)

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
por: Zulian, G. B., et al.
Publicado: (1989)

Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
por: Perren, T. J., et al.
Publicado: (1990)

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
por: Kaye, S. B., et al.
Publicado: (1979)

Lattice QCD calculation using VPP500
por: Kim, S, et al.
Publicado: (1994)

High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.
por: O'Brien, M. E., et al.
Publicado: (1996)

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.
por: Lakhani, S., et al.
Publicado: (1990)

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
por: Mbidde, E. K., et al.
Publicado: (1988)

AntiVPP 1.0: A portable tool for prediction of antiviral peptides
por: Beltrán Lissabet, Jorge Félix, et al.
Publicado: (2019)

Effects of milk-derived bioactive peptide VPP on diarrhea of pre-weaning calves
por: Zong, Xiaomei, et al.
Publicado: (2023)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

Concurrent malignant melanoma and cutaneous involvement by classical hodgkin lymphoma (CHL) in a 63 year-old man
por: Gru, Alejandro A, et al.
Publicado: (2013)

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
por: Nohtani, Mahdi, et al.
Publicado: (2022)

Changing patterns of relapse in Hodgkin's disease.
por: Duchesne, G., et al.
Publicado: (1989)

P1090: CAMRELIZUMAB (CAM) COMBINED WITH GEMOX CHEMOTHERAPY RESULTS IN HIGH COMPLETE METABOLIC RESPONSE RATES IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA (CHL): A PHASE II TRIAL
por: Xie, Y., et al.
Publicado: (2022)

Mind Perception: Real but Not Artificial Faces Sustain Neural Activity beyond the N170/VPP
por: Wheatley, Thalia, et al.
Publicado: (2011)

High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice
por: Li, Feng, et al.
Publicado: (2010)

The Vivitrol pilot program (VPP): initial quantitative findings from an extended-release naltrexone study
por: Rieckmann, Traci, et al.
Publicado: (2015)

Repeat administration of high dose melphalan in relapsed myeloma.
por: Mansi, J. L., et al.
Publicado: (1993)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
por: Inaoka, Riguel J, et al.
Publicado: (2011)

Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival.
por: Eeles, R. A., et al.
Publicado: (1991)

Maize ZmVPP5 is a truncated Vacuole H(+)‐PPase that confers hypersensitivity to salt stress
por: Sun, Xiaoliang, et al.
Publicado: (2016)

Co-Expression of ZmVPP1 with ZmNAC111 Confers Robust Drought Resistance in Maize
por: Liu, Shengxue, et al.
Publicado: (2022)

A Note on the Geometry of CHL Heterotic Strings
por: Lerche, Wolfgang, et al.
Publicado: (1997)

P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
por: Chen, Robert, et al.
Publicado: (2015)

The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
por: Rajabto, Wulyo, et al.
Publicado: (2022)

S215: KEYNOTE-667: OPEN-LABEL, PHASE 2 STUDY OF PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT-LINE CHEMOTHERAPY
por: Vinti, Luciana, et al.
Publicado: (2023)

Multifunctional Medical Grade Resin with Enhanced Mechanical and Antibacterial Properties: The Effect of Copper Nano-Inclusions in Vat Polymerization (VPP) Additive Manufacturing
por: Vidakis, Nectarios, et al.
Publicado: (2022)

Structural characterisation of the Chaetomium thermophilum Chl1 helicase
por: Hodáková, Zuzana, et al.
Publicado: (2021)

Study on CerAMfacturing of Novel Alumina Aerospike Nozzles by Lithography-Based Ceramic Vat Photopolymerization (CerAM VPP)
por: Schwarzer-Fischer, Eric, et al.
Publicado: (2022)

Peripheral blood involvement in non-Hodgkin's lymphoma detected by clonal gene rearrangement as a biological prognostic marker.
por: Hiorns, L. R., et al.
Publicado: (1994)

P013: Outcomes of first-line treatment (FL) of classical Hodgkin lymphoma (cHL) in Argentina: a real life multicenter retrospective study
por: Laura, Korin, et al.
Publicado: (2022)

Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.
por: Brada, M., et al.
Publicado: (1987)

Four-derivative couplings and BPS dyons in heterotic CHL orbifolds
por: Bossard, Guillaume, et al.
Publicado: (2017)

CHL1 gene polymorphisms increase lung cancer susceptibility
por: Tian, Wen, et al.
Publicado: (2018)

Variations in the Distribution of Chl-a and Simulation Using a Multiple Regression Model
por: Deng, Jiancai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1n5u64f4v81pg673sheqomoo6o